Morphology of Immunomodulation in Breast Cancer Tumor Draining Lymph Nodes Depends on Stage and Intrinsic Subtype

Maximilian Seidl, M Bader, Astrid Vaihinger, Ulrich F. Wellner, Rumyana Todorova, Bettina Herde, Klaudia Schrenk, Jochen Maurer, Oliver Schilling, Thalia Erbes, Paul Fisch, Jens Pfeiffer, Linda S. Hoffmann, Kai Franke, Martin Werner, Peter BronsertScientific 2018 · DOI

TL;DR

This study reveals that the microscopic structure of lymph nodes draining breast tumors changes significantly based on the tumor's subtype and stage. These changes in lymph node architecture, particularly in follicles and germinal centers, are not random but reflect distinct immune responses and could serve as valuable markers for predicting prognosis and guiding immunomodulatory therapies.

What Problem Does This Paper Address?

While much cancer research focuses on immune cells within the tumor itself, the immune system's initial response and modulation at the primary activation site – the draining lymph node (LN) – has been less explored. These LNs are crucial for initiating adaptive immunity and are the first stop for tumor-derived signals and cells. Understanding how tumors alter the structure of these draining LNs could provide critical insights into immune evasion, metastasis, and potential therapeutic targets. The challenge is to systematically analyze these subtle, yet potentially significant, morphological changes and link them to specific tumor characteristics.

Methods

The researchers conducted a quantitative histomorphological study on 206 breast cancer patients. They meticulously analyzed lymph node samples, specifically focusing on sentinel LNs (the first to receive lymphatic drainage) and non-sentinel LNs (other regional LNs). Using H&E and IgD staining, they digitally scanned and analyzed thousands of LNs, identifying and measuring structures like follicles, germinal centers, and cortical macrophages. They developed quantitative metrics for follicle and germinal center density, roundness (circularity), and mantle zone size. These morphological parameters were then correlated with various clinicopathological features, including tumor stage (pT), nodal status (pN), tumor grade (G), hormone receptor status (ER, PR), HER2 status, and importantly, the intrinsic molecular subtype of the breast cancer. Statistical analyses, including univariate and multivariate linear regression, were employed to identify significant associations.

Datasets

The study utilized a dataset of 206 breast cancer patients who underwent surgery between 2003 and 2013. This cohort included 1334 lymph node samples (394 sentinel and 940 non-sentinel LNs), containing over 40,000 follicles and 7,000 germinal centers. The data was collected from patients with existing sentinel LNs, no neoadjuvant therapy, and no prior anti-hormonal treatment.

Key Insights and Ideas

  • Lymph Nodes as Active Players: The study strongly suggests that draining lymph nodes are not passive bystanders but are actively remodeled by the tumor, reflecting a dynamic interplay between the tumor and the host immune system.
  • Subtype-Specific Immune Signatures: Different intrinsic breast cancer subtypes (e.g., Luminal-A, Luminal-B, HER2-enriched, Triple-negative) induce distinct morphological changes in the draining LNs, hinting at subtype-specific immune evasion or activation strategies.
  • Morphology as a Biomarker: The observed changes in LN morphology (follicle density, shape, macrophage infiltration) are not just descriptive but show significant correlations with tumor stage and subtype, suggesting their potential as prognostic and predictive biomarkers.
  • Sentinel vs. Non-Sentinel Differences: There are discernible differences between sentinel and non-sentinel LNs, with non-sentinel LNs often showing rounder follicles and germinal centers, and lower cortical macrophage infiltration, indicating a gradient of tumor influence.

Key Results

  • Follicular Density: Higher follicular density was observed in LNs draining HER2-enriched and triple-negative breast cancers, while hormone receptor-positive breast cancers showed more macrophage infiltration in the LN cortex.
  • Follicle Shape: Follicles and germinal centers were rounder in metastatic LNs and non-sentinel LNs, suggesting a more organized immune response in these locations or a disruption of normal architecture in earlier stages.
  • Macrophage Infiltration: Luminal-A and -B subtypes were associated with higher cortical macrophage infiltrations, whereas HER2-enriched and triple-negative subtypes showed lower infiltrations.
  • Tumor Stage Impact: Advanced tumor stage (higher pT category) correlated with increased follicular and germinal center density and roundness, and smaller mantle zones.
  • Hormone Receptor Impact: Estrogen and progesterone receptor positivity correlated with increased cortical macrophage infiltration and decreased tumor-infiltrating lymphocytes (TILs) in the primary tumor.

Limitations and Future Work

The authors acknowledge that while their study identified significant correlations, the direct causal mechanisms behind these morphological changes require further investigation. They also note that the number of disease-associated deaths in their cohort was too low to establish independent effects on overall survival. Future work could focus on elucidating the functional significance of these observed immunomorphological patterns, exploring their predictive value for response to immunomodulatory therapies (like checkpoint inhibitors), and investigating the role of specific immune cell populations (e.g., Tfh cells, macrophages) in shaping these LN structures. Further studies are needed to characterize the functional background of these different immunomorphologies for their therapeutic targeting.

Summary updated

Abstract

Cancer research of immune-modulating mechanisms mainly addresses the role of tumor-infiltrating immune cells. Mechanisms modulating the adaptive immune system at the primary activation site - the draining lymph node (LN) - are less investigated. Here we present tumor-caused histomorphological changes in tumor draining LNs of breast cancer patients, dependent on the localization (sentinel LN vs. non-sentinel LN), the tumor size, the intrinsic subtype and nodal metastatic status. The quantitative morphological study was conducted in breast cancer patients with at least one sentinel LN and no neoadjuvant therapy. All LNs were annotated considering to their topographical location, stained for IgD/H&E, digitized and quantitatively analyzed. In 206 patients, 394 sentinels and 940 non-sentinel LNs were categorized, comprising 40758 follicles and 7074 germinal centers. Subtype specific immunomorphological patterns were detectable: Follicular density was higher in LNs of Her2 enriched hormone receptor positive and triple-negative breast cancers whereas hormone receptor positive breast cancers showed more macrophage infiltrations in the LN cortex. Follicles are rounder in metastatic LNs and non-sentinel LNs. The identified immunomorphological changes reflect different underlying immunomodulations taking place in the tumor-draining LNs and should therefore be considered as possible prognostic and predictive markers for LN metastasis and therapy associated immunomodulation.
BibTeX
@inproceedings{seidl2018morphology,
  author = {Maximilian Seidl and M Bader and Astrid Vaihinger and Ulrich F. Wellner and Rumyana Todorova and Bettina Herde and Klaudia Schrenk and Jochen Maurer and Oliver Schilling and Thalia Erbes and Paul Fisch and Jens Pfeiffer and Linda S. Hoffmann and Kai Franke and Martin Werner and Peter Bronsert},
  title = {{Morphology of Immunomodulation in Breast Cancer Tumor Draining Lymph Nodes Depends on Stage and Intrinsic Subtype}},
  booktitle = {Scientific},
  year = {2018},
  doi = {10.1038/s41598-018-23629-3},
}
Figure